. EnyartJJ, JonesRJ. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery. Ann Pharmacother2005; 39: 1002–7. Epub 10 May 2005. DOI 10.1345/aph.1E536
2.
. WhiteRH, RomanoPS, ZhouH, RodrigoJ, BargarW. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med1998; 158: 1525–31.
3.
. CompPC, SpiroT, FriedmanRJ, WhittsettTL, JohnsonGJ, GardinerGAJr, Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. Enoxaparin Clinical Trial Group. J Bone Joint Surg Am2001; 83-A: 336–45.
4.
. MoherD, SchulzKF, AltmanDG, for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet2001; 357: 1191–4.
5.
. GeertsWH, PineoGF, HeitJA, BergqvistD, LassenMR, ColwellCW, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004; 126 (3 suppl): 338S–400S.
